It is caused by a mutation of the dystrophin gene and characterized by a progressive loss of skeletal muscle function. Most patients also develop a dystrophic cardiomyopathy, resulting in dilated hypertrophy and heart failure, but the cellular mechanisms leading to the deterioration of cardiac function remain elusive. In the present study, we tested whether defective excitation-contraction (E-C) coupling contributes to impaired cardiac performance. "E-C coupling gain" was determined in cardiomyocytes from control and dystrophin-deficient mdx mice. To this end, L-type Ca 2ϩ currents (ICaL) were measured with the whole cell patch-clamp technique, whereas Ca 2ϩ transients were simultaneously recorded with confocal imaging of fluo-3. Initial findings indicated subtle changes of E-C coupling in mdx cells despite matched Ca 2ϩ loading of the sarcoplasmic reticulum (SR). However, lowering the extracellular Ca 2ϩ concentration, a maneuver used to unmask latent E-C coupling problems, was surprisingly much better tolerated by mdx myocytes, suggesting a hypersensitive E-C coupling mechanism. Challenging the SR Ca 2ϩ release by slow elevations of the intracellular Ca 2ϩ concentration resulted in Ca 2ϩ oscillations after a much shorter delay in mdx cells. This is consistent with an enhanced Ca 2ϩ sensitivity of the SR Ca 2ϩ -release channels [ryanodine receptors (RyRs)]. The hypersensitivity could be normalized by the introduction of reducing agents, indicating that the elevated cellular ROS generation in dystrophy underlies the abnormal RyR sensitivity and hypersensitive E-C coupling. Our data suggest that in dystrophin-deficient cardiomyocytes, E-C coupling is altered due to potentially arrhythmogenic changes in the Ca 2ϩ sensitivity of redox-modified RyRs.
ryanodine receptor; calcium signaling; muscular dystrophy DUCHENNE MUSCULAR DYSTROPHY (DMD) belongs to the large group of dystrophinopathies, in which cytoskeletal abnormalities and remodeling may lead to heart failure (18, 36) . DMD represents the most severe genetic muscular disorder affecting striated muscle. It results from mutations in the dystrophin gene, which encodes for the cytoskeletal protein dystrophin (8) . At the cellular level, dystrophin forms a molecular bridge between the F-actin of the cytoskeleton and the extracellular matrix via the dystroglycan protein complex, thus providing mechanical stability to the myocyte. Lack of dystrophin expression disrupts the dystroglycan complex and is thought to confer instability to the cytoskeleton and plasma membrane with a severe impact on cellular signaling. The disease affects 1 in 3,000 boys with the onset of complications in early childhood. Disease symptoms ultimately lead to premature death, mostly due to respiratory failure. Progressive skeletal muscle wasting in DMD is also accompanied by the development of cardiac abnormalities, such as fibrosis with wall motion malfunctions, left ventricular dysfunction, and ventricular arrhythmias, leading to dilated cardiomyopathy and cardiac failure (11) . Since therapy progress at the level of skeletal muscle wasting has significantly improved the life expectancy of DMD patients over the years, dystrophic cardiomyopathy becomes more and more a limiting factor in the (symptomatic) treatment of DMD patients. An established animal model for studying the disease phenotype of DMD is the mdx mouse, where, in analogy to DMD mutations, a point mutation in the dystrophin gene leads to an untranslatable gene (16, 21) . Similar to humans, mdx mice show an age-linked disease onset of cardiomyopathy resulting in cardiac dilation, a progressive decrease in fractional shortening, replacement of the functional myocardium by fibrotic tissue, and, thus, conduction defects (5, 31) .
A previous study (41) of the mdx mouse showed substantial changes in Ca 2ϩ signaling with only slightly elevated levels of resting intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) in ventricular myocytes. In addition, dystrophic myocytes exhibit an increased susceptibility to mechanical stress-induced Ca 2ϩ influx across the sarcolemma, possibly via microruptures, stretchactivated channels, and other pathways as a consequence of the disrupted dystroglycan complex (9, 20, 41, 45) . This allows for excessive Ca 2ϩ influx via voltage-independent pathways during mechanical stress, which is then synergistically amplified by several cellular mechanisms to generate excessive cytosolic and mitochondrial Ca 2ϩ transients and irreversible loss of mitochondrial membrane potential, an early indication of cell death (20) . Excessive production of ROS in these cells was identified as a mechanism contributing to this disproportionate Ca 2ϩ signal amplification (20, 42) . Since ryanodine receptors (RyRs) become more Ca 2ϩ sensitive after oxidation (30) , the simultaneous activation of Ca 2ϩ -induced Ca 2ϩ release (CICR) and ROS production in dystrophic myocytes could be the mechanism leading to cellular damage. Functional incapability of precise intracellular Ca 2ϩ regulation might be an early indicator of changes in Ca 2ϩ sensitivity and may have a large impact on excitation-contraction (E-C) coupling and cell survival in the long run.
The goal of the present study was to investigate impairments of E-C coupling in dystrophic cardiomyopathy. In progressive cardiomyopathies, disturbance of the E-C coupling mechanism often contributes to decreased cardiac performance. For example, in several animal models for heart failure, it has been shown that at similar L-type Ca 2ϩ current (I CaL ) amplitude, there is a significant reduction in CICR, resulting in smaller Ca 2ϩ transients and decreased myocyte contractility (14, 26, 35) . A reduction in the ability of the Ca 2ϩ current to trigger Ca 2ϩ release from the sarcoplasmic reticulum (SR) can indicate a reduced sensitivity of the E-C coupling machinery toward Ca 2ϩ . Therefore, we expected alterations of E-C coupling in dystrophy to be similar to those observed in other forms of cardiomyopathy, with a reduced reliability of signal transmission between L-type Ca 2ϩ channels and RyRs. Opposite to these expectations, our data indicated an abnormal ability of dystrophic myocytes to cope with experimental tests designed to challenge E-C coupling mechanisms, which points to a hypersensitivity of E-C coupling rather than to the reduced efficiency of E-C coupling found in other cardiac pathologies. Our results suggest that the hypersensitive E-C coupling results, at least in part, from an increased probability of RyRs to be activated by Ca 2ϩ , which may be the consequence of an imbalance in redox regulation in dystrophic myocytes. While such hypersensitivity may initially represent a beneficial mechanism to maintain E-C coupling in the disease, it may also have negative consequences, for example, by increasing the propensity for arrhythmias.
Some preliminary data of this study have been presented in abstract form (39) .
MATERIALS AND METHODS
Cell isolation. Adult C57BL10 mice [wild-type (WT) mice] at the age of 6 -12 mo and age-matched dystrophin-deficient mdx mice (C57BL/10ScSn-mdx mice) were used in this study. At this age, mdx mice begin to develop a dilated cardiomyopathy but are not in overt heart failure (31). Animals were provided by Dr. M. Rüegg (University of Basel, Basel, Switzerland) and Dr. U. Rüegg (University of Geneva, Geneva, Switzerland) or were purchased from the Jackson Laboratory. Mouse hearts were rapidly excised after cervical dislocation, immersed in cold Ca 2ϩ -free saline buffer, and trimmed of excess tissue. Hearts were then cannulated and placed on a Langendorff perfusion apparatus. Enzymatic dissociation of ventricular myocytes was performed as previously described (43 Starting from a holding potential of Ϫ80 mV, the voltage protocol consisted of an initial step to Ϫ40 mV for 2 s. When corrected for the tip potential, this would correspond to a real potential of Ϫ52 mV, which inactivates voltage-dependent Na ϩ and T-type Ca 2ϩ currents. This inactivation step was followed by 8 pulses of 50 ms to 0 mV at 1 Hz and then by a 400-ms depolarization to various test voltages. The initial preconditioning pulses were always applied in control solution and served to equalize the SR Ca 2ϩ load before each test step, which was recorded at different extracellular Ca 2ϩ concentrations ([Ca 2ϩ ]o). Subsequent to the loading pulses, the membrane voltage was kept at Ϫ40 mV for 4 s to allow for the complete exchange of extracellular solution by rapid local perfusion (half-life Ͻ 0.5 s). The full voltage protocol is shown in Fig. 1A .
Confocal microscopy. Changes in [Ca 2ϩ ]i were simultaneously measured with ionic currents using the fluorescent Ca 2ϩ indicator K5-fluo-3 (100 M, Biotium) and a laser-scanning confocal microscope (MicroRadiance, Bio-Rad). Fluo-3 was excited with the 488-nm line of an argon ion laser. The emitted light was collected above 500 nm. The acquisition of line-scan images along the cardiomyocytes was triggered by the LabView software 400 ms before the last loading pulse. Line-scan images were recorded for 6 s at a rate of 500 lines/s and captured the last prepulse, the period for solution exchange, and the test step at the end of the voltage protocol.
In experiments with intact ventricular cardiomyocytes (i.e., not dialyzed with a pipette filling solution), intracellular Ca 2ϩ signals were recorded by full-frame image acquisition. Cells were loaded with fluo-3 by exposure to the membrane-permeant ester fluo-3 AM (5 M, Biotium) for 30 min at room temperature followed by at least 10 min of deesterification. Images were acquired using a laser-scanning confocal microscope (MRC 1000, Bio-Rad). Fluo-3 was excited at 488 nm with a solid-state laser (Sapphire, Coherent), and fluorescence detection was performed at 540 Ϯ 15 nm. Cells were continuously superfused with extracellular solution containing (in mM) 140 NaCl, 5.4 KCl, 1.8 CaCl 2, 1.1 MgCl2, 5 HEPES, and 10 glucose at pH 7.4. Different test solutions contained 70 mM NaCl and 70 mM LiCl, or 140 mM LiCl instead of 140 mM NaCl. The osmolality was 310 mosM for all solutions.
Thapsigargin and ryanodine were from Alamone Laboratories, Mn-cpx3 was from Calbiochem, and mercaptopropionyl-glycine (MPG) was from Sigma-Aldrich. All experiments were performed at room temperature (22°C).
Data analysis. Electrophysiological data were analyzed using IgorPro software (Wavemetrics). Current inactivation was fitted with a double-exponential function. Confocal images were initially analyzed using Image SXM [free software based on NIH Image (3)] and further processed by IgorPro. Fluorescence changes (⌬F/F 0) during Ca 2ϩ transients in line-scan images were fitted with a sigmoidal function to determine peak amplitude and rise time.
Significance was tested by Student's t-test. Values of P Ͻ 0.05 were considered significant. Pooled data are given as means Ϯ SE, with n representing the number of cells tested. In the figures and table, significance is indicated by *P Ͻ 0.05 and **P Ͻ 0.01.
RESULTS

I CaL , cytosolic Ca 2ϩ transients, and E-C coupling gain in WT and dystrophic cardiomyocytes.
During cardiac E-C coupling, depolarization-induced Ca 2ϩ influx through L-type Ca 2ϩ channels triggers Ca 2ϩ release from the SR via CICR, which subsequently initiates the contraction of cardiac muscle cells. Figure 1 shows the voltage protocol (A), representative traces of I CaL , and corresponding cytosolic Ca 2ϩ signals at peak activation [maximal current amplitude at 0 mV (I max )] in WT (B) and mdx (C) myocytes. At similar trigger I max , SR Ca 2ϩ release reached comparable amplitudes in both WT (n ϭ 20) and mdx myocytes (n ϭ 16; see also Table 1 ). The voltage of test steps ranged from Ϫ25 to ϩ50 mV. The current-voltage relationship and the associated voltage dependence of cytosolic Ca 2ϩ transients under control conditions are shown in Fig. 1D . Analysis of the E-C coupling gain provides an estimate of the coupling fidelity between L-type Ca 2ϩ channels and RyRs. It is determined by normalizing the amplitude of the cytosolic Ca 2ϩ transient to the corresponding amplitude of I CaL at each given voltage. When performing this E-C coupling analysis, gain was comparable in dystrophic and WT myocytes, particularly at positive test voltages, as expected from the similarity in Ca 2ϩ current amplitudes and Ca 2ϩ transients (Fig. 1E ). At negative membrane voltages, the E-C coupling gain was always largest, possibly due to higher coupling fidelity between the L-type Ca 2ϩ channel and RyR and less redundant Ca 2ϩ current (1). However, under control conditions, the gain was only insignificantly reduced in mdx cells at Ϫ25 mV (3.58 Ϯ 0.39, n ϭ 21, and 2.66 Ϯ 0.38, n ϭ 28, at Ϫ25 mV in WT and mdx cells, respectively).
Thus, in contrast to observations in several other cardiac pathologies, such as hypertrophy and heart failure (4, 14, 28) , the efficiency of E-C coupling in dystrophic myocytes did not seem to be affected under control conditions. I CaL , cytosolic Ca 2ϩ transients, and E-C coupling gain at threshold conditions. At physiological [Ca 2ϩ ] o , the E-C coupling machinery is optimized to produce reliable E-C coupling in cardiomyocytes and may therefore be able to compensate for subtle problems resulting from a disease. To detect changes in the functionality of the involved key proteins, the system may be tested under conditions that challenge the efficiency of the E-C coupling mechanism. Lowering the [Ca 2ϩ ] o has previ- ously been successfully used as an experimental tool to unmask subtle impairments of E-C coupling in a diseased heart (28) . Therefore, we repeated the experiments shown in Fig. 1 Figure 3E shows the E-C coupling gain in WT and mdx myocytes at Ϫ25 mV in 0. ] o unmasked an unusual resistance to reductions in triggering I CaL in mdx myocytes and resulted in an abnormal increase in the E-C coupling gain. Again, this reflects a behavior that is opposite to the results from previous studies of altered E-C coupling in cardiac diseases, such as heart failure (4, 14, 28 (Fig. 4, A and B) . Whereas at 70 mM extracellular Na ϩ the frequency of oscillations was still comparable in the two types of myocytes (0.27 Ϯ 0.05 Hz, n ϭ 19, and 0.29 Ϯ 0.02 Hz, n ϭ 9, in WT and mdx cells, respectively), it was significantly higher upon complete removal of Na ϩ in mdx myocytes (0.39 Ϯ 0.04 Hz, n ϭ 19, and 0.68 Ϯ 0.08 Hz, n ϭ 8; Fig. 4C ). Equally important, Ca 2ϩ oscillations at reduced Na ϩ occurred significantly earlier in mdx cells (after 23.1 Ϯ 4.1 vs. 8.87 Ϯ 1.69 s in 70 mM Na ϩ and 13.0 Ϯ 2.1 vs. 5.1 Ϯ 0.4 s in 0 mM Na ϩ in WT and mdx cells, respectively; Fig. 4D ). While the higher frequency of Ca 2ϩ oscillations can have several reasons, the shorter delay is a hallmark of increased RyR Ca 2ϩ sensitivity (19). To verify that the above observations are linked to a putatively increased Ca 2ϩ sensitivity of RyRs in mdx myocytes, but not to changes in NCX activity itself, we estimated the influx of Ca 2ϩ via NCX while eliminating SR function. The latter was achieved by the incubation of cells with thapsigargin (1 M) and ryanodine (10 M). Figure 5A shows a representative trace of slow changes in [Ca 2ϩ ] i elicited by the rapid removal of external Na ϩ in a WT cardiomyocyte. Figure 5B shows the results of similar experiments in all WT (n ϭ 11) and mdx (n ϭ 5) cells studied with this protocol. There were no significant differences detected in the NCX- (Fig. 6) . Figure 6A shows representative intracellular Ca 2ϩ transients elicited by 10 mM caffeine in WT and mdx myocytes in patch-clamped cells at Ϫ40 mV. Figure  6B shows the averaged amplitudes of Ca 2ϩ transients as estimated from caffeine-induced Ca 2ϩ transients (2.88 Ϯ 0.32 ⌬F/F 0 in WT cells and 3.49 Ϯ 0.33 ⌬F/F 0 in mdx myocytes, respectively, n ϭ 10 and 13). In the presence of 8 mM [Na ϩ ] i , SR Ca 2ϩ content increased to 4.61 Ϯ 0.68 ⌬F/F 0 in WT cells and 4.72 Ϯ 0.38 ⌬F/F 0 in mdx cells, respectively (n ϭ 8 in both groups; not shown). Thus, SR Ca 2ϩ content was not significantly different between WT and mdx cells at either [Na ϩ ] i (P ϭ 0.89 and P ϭ 0.21 at 8 and 0 mM, respectively).
Integrated NCX currents activated by caffeine-induced Ca 2ϩ transients are more reliable estimates of SR Ca 2ϩ content because they do not depend on the particular time course of the caffeine-induced Ca 2ϩ release. These estimates were even more similar in both types of myocytes than those derived from fluorescence transients (Fig. 6, C and D) . Figure 6C to 0 mV. As before, the test depolarization was preceded by a series of preconditioning pulses to optimize SR Ca 2ϩ load. Figure 6E shows (Fig. 6F ). Taken together, these results indicates that there were no significant differences in SR Ca 2ϩ content between WT and mdx cells under our experimental conditions. Therefore, luminal Ca 2ϩ is unlikely to explain the observed enhanced Ca 2ϩ sensitivity of RyRs and hypersensitive E-C coupling in mdx myocytes.
E-C coupling gain in the presence of ROS scavengers.
There is increasing evidence of oxidative stress in the dystrophic heart, which is caused by an imbalance in the production of ROS and the cell's innate capability to inactivate them (20, 42) . Permanent exposure of the cells to increased levels of ROS may severely damage several components of the cell, resulting in cell death. In a recent study (20) , we found abnormally elevated ROS levels in dystrophic cardiomyocytes both at rest and after mechanical stress.
The RyR contains a number of free cysteine residues, which are prone to redox modifications. In the case of oxidation of the cytosolic environment, free and neighbored thiol groups may form disulfide bonds, thereby altering the secondary structure of the RyR and increasing its sensitivity to Ca 2ϩ activation (10) . We speculated that the increased intracellular levels of ROS observed previously may be responsible for the abnormal Ca 2ϩ sensitivity of RyRs and consequently lead to unusually reliable E-C coupling in dystrophic myocytes. Therefore, we tested whether a reduction of cytosolic ROS levels would normalize E-C coupling in dystrophic myocytes. For these experiments, we used two approaches: 1) the addition of a synthetic compound (Mn-cpx3) that acts as a natural SOD mimetic, which helps to maintain a reducing environment within the cell; and 2) the addition of a general antioxidant (MPG), which directly interacts with the oxidized protein and reduces it.
Preincubation of mdx cells with either 10 M Mn-cpx3 or 800 M MPG for 30 min normalized SR Ca 2ϩ release during E-C coupling under conditions of reduced [Ca 2ϩ ] o and eliminated the hypersensitivity of E-C coupling. Figure 7 shows the averaged E-C coupling gain in dystrophic cardiomyocytes preconditioned with Mn-cpx3 and MPG, respectively, and studied in 0.5 and 0.25 mM [Ca 2ϩ ] o . For better comparison, these data are shown together with some that are replotted from Figs. 2C and 3E. The E-C coupling gain of mdx myocytes pretreated with Mn-cpx3 or MPG was no longer significantly different from that in WT cells. Thus, reduction of intracellular levels of ROS and oxidative stress eliminated the hypersensitivity of RyRs toward Ca 2ϩ and restored normal E-C coupling gain in dystrophic myocytes. Since RyRs are redox sensitive even at normal cytosolic redox potentials (10), treatment of WT myocytes with MPG also led to a reduction of E-C coupling gain, as expected.
DISCUSSION
Patients suffering from muscular dystrophy develop early cardiomyopathy with reduced cardiac force. Therefore, we expected that the contractility of dystrophic cardiomyocytes would be diminished. In particular, we anticipated that E-C coupling would be impaired. Surprisingly, our study revealed an extremely reliable E-C coupling mechanism in dystrophic cardiomyocytes, which is even more resistant to experimental challenges than in WT cells. This unique feature has not been previously observed in studies of other cardiac pathologies and may be due to an increased sensitivity of RyRs to Ca 2ϩ resulting from redox modification of the channel proteins.
E-C coupling in dystrophic cardiomyocytes. E-C coupling comprises the early steps that link electrical excitation of the cardiac muscle to mechanical contraction. The quality of the E-C coupling mechanism can be assessed by the E-C coupling gain, which is a measure for the effectiveness of a cardiomyocyte to amplify the Ca 2ϩ influx via L-type Ca 2ϩ channels by triggered Ca 2ϩ release from the SR. Amplification of the cardiac Ca 2ϩ signal is well controlled and not only depends on Ca 2ϩ influx via L-type Ca 2ϩ channels but also on the complex regulation of RyRs and accessory proteins as well as on SR Ca 2ϩ content, ultrastructural features, and the metabolic state of the cell. Therefore, the amplification mechanisms are likely to be affected in various diseases. So far, only a few studies have specifically investigated this phenomenon by focusing on the actual E-C coupling mechanism. They found that the E-C coupling gain is significantly decreased in several animal models of heart failure or dilated cardiomyopathies (for examples, see Refs. 4, 12, 14, 26, 28, and 35) . The reduction in E-C coupling gain could be, at least partially, responsible for the decreased cardiac contractility in these pathologies (but see Ref. 38) .
In our present study, there was no obvious deficiency found when E-C coupling was analyzed under control conditions. Since E-C coupling presumably incorporates a high degree of reliability, this mechanism may have a large margin of safety, and small shifts in its sensitivity may not lead to obvious signaling disturbances. Thus, we needed experimental conditions to unmask even subtle alterations of E-C coupling. Our method to discover such changes was to challenge E-C coupling by reducing [Ca 2ϩ ] o . This procedure has already proven useful in a previous study by McCall et al. (28) , who showed that reducing the trigger signal for CICR by lowering [Ca 2ϩ ] o can be used to reveal slight E-C coupling problems in heart failure. Whereas this test was well tolerated by control cells, in their study it lead to a pronounced and disproportionate decrease in contractile function in myocytes from failing hearts at similar trigger Ca 2ϩ currents. In our experiments, we used this method to reduce the safety margin for functional E-C coupling, so that the system does not operate above saturation any longer. With this approach, changes in the coupling between I CaL and RyR Ca 2ϩ release are easier to uncover. When compared with the study on heart failure mentioned above (28) , the dystrophic cardiomyocytes examined here behaved in the exact opposite way. Acutely lowering [Ca 2ϩ ] o reduced Ca 2ϩ release from the SR to a lesser extent in mdx cardiomyocytes than in WT cardiomyocytes. This resulted in an increase of E-C coupling gain, not only relative to that in WT cells but also compared with the gain at control [Ca 2ϩ ] o . At this point, it is important to mention again that all experiments have been performed at matching SR Ca 2ϩ load. Using our voltage protocol, conditioning pulses were always applied in control [Ca 2ϩ ] o , and only the test step that directly followed the loading pulses was applied in different reduced [Ca 2ϩ ] o . The discovery of Ca 2ϩ hypersensitivity at reduced [Ca 2ϩ ] o does not mean that this hypersensitivity is not present under normal conditions. It may just be masked by the already redundant activation of RyRs during E-C coupling and is therefore best identified at smaller trigger I CaL (1) . Thus, the physiological or pathophysiological relevance of the hypersensitivity is not limited to depolarizations to Ϫ25 and 0 mV but present for the entire range of membrane potentials that are covered during the cardiac action potential (see Fig. 2B ). Therefore, our data indicate a hypersensitive E-C coupling mechanism in dystrophic cardiomyocytes, which are more resistant to this specific experimental challenge.
Altered Ca 2ϩ sensitivity in dystrophic cardiomyocytes. Increased E-C coupling gain actually means that Ca 2ϩ is more easily released from the SR at similar trigger I CaL . Since the properties of I CaL in mdx myocytes showed no difference compared with WT myocytes, the critical changes of E-C At the level of the microarchitecture, it is conceivable that loss of the cytoskeletal protein dystrophin causes disarrangements in the dyadic cleft and disruption of the coupling between the L-type Ca 2ϩ channel and RyR. However, one would expect that such structural changes lead to a reduction in the apparent Ca 2ϩ sensitivity of the RyR and to a decrease in the E-C coupling gain. Such loss of function has been reported for a cardiac myocyte hypertrophy model (13) . Pressure overload of the cardiomyocytes resulted in the disruption of the cytoskeleton, a significant decrease in E-C coupling efficiency, and a reduction in cardiac output. In contrast, a significant gain in the sensitivity of E-C coupling was observed in dystrophic cardiomyocytes. An increase in [Ca 2ϩ ] SR can also have profound consequences on RyR function and intracellular Ca 2ϩ signaling (23), leading to elevated RyR Ca 2ϩ sensitivity and even to spontaneous SR Ca 2ϩ -release events like Ca 2ϩ waves (22) . Potential alterations in the expression and function of several major SR-related proteins, such as RyRs, SR Ca 2ϩ pumps, and load (2, 7, 15, 44) . We and others (20, 42) have recently reported an increased basal ROS production in the dystrophic heart. In addition, we (20) have previously shown that ROS generated by NAD(P)H oxidase and mitochondria are causally involved in the excessive Ca 2ϩ signaling response to mechanical stress observed in mdx cardiomyocytes. Recently, it was found that oxidative stress during overt heart failure can lead to RyR oxidation and elevated Ca 2ϩ sensitivity, thus contributing to the elevated SR Ca 2ϩ leak (37) . Abnormal levels of ROS in dystrophic cardiomyocytes might therefore contribute to the enhanced Ca 2ϩ sensitivity of RyRs and to the increased E-C coupling gain when the cardiomyopathy has not yet evolved into heart failure. Our experiments using reducing agents support the latter possibility. We (20) have previously shown that a number of different ROS reducing substances (MnTBAP, Mn-cpx3, tiron, and apocynin) effectively normalized the stress sensitivity of dystrophic cardiomyocytes. In the present study, we used Mncpx3, which acts as a SOD mimetic, and MPG, which directly reduces the proteins. Reducing the cytosolic ROS concentration and oxidative stress by these means eliminated the hypersensitive E-C coupling in mdx cells. Although through different mechanisms, both tested substances more or less led to the normalization of E-C coupling gain in dystrophic myocytes, suggesting that protein oxidation may indeed be involved. As expected, treatment of WT myocytes with the reducing agent MPG led to some reduction in E-C coupling gain, since the RyR open probability is also sensitive to changes in cytosolic redox potentials, even in normal animals (10) .
Under normal and healthy conditions, RyR hypersensitivity by itself may not lead to any dramatic changes in E-C coupling. However, if we extrapolate our findings to conditions of mechanical stress and undue Ca 2ϩ accumulation (due to microruptures and other voltage-independent Ca 2ϩ influx pathways), as it is suspected for dystrophic myocytes, one can imagine that excess cytosolic Ca 2ϩ may easily activate hypersensitive RyRs and initiate spontaneous, arrhythmogenic Ca 2ϩ release from the SR-and even more so during ␤-adrenergic stimulation (29) . Related to this notion, it is believed that in the presence of RyR hypersensitivity the combination of two (or more) proarrhythmogenic mechanisms dramatically increases the susceptibility for arrhythmias (40) . In an animal model harboring a gain of function mutation in the cardiac RyR, such a "double-hit" scenario has been observed directly (6) .
Similarly, hypersensitivity of RyRs caused by several recently discovered RyR mutations is known to have profound arrhythmogenic potential. In these patients, catecholaminergic polymorphic ventricular tachycardias (CPVTs) can be triggered by physical or emotional stress and cause sudden cardiac arrest (24) . Thus, we speculate that the frequent CPVTs observed in dystrophic patients may also be linked to RyR hypersensitivity, at least in part (25) . The fact that RyR Ca 2ϩ hypersensitivity and E-C coupling gain can be normalized in Conclusions. The key result of our study is the discovery of a RyR hypersensitivity for Ca 2ϩ due to redox modifications in dystrophic cardiomyopathy, which is not only responsible for excessive stress responses but also changes the signal transduction linking L-type Ca 2ϩ channels to RyRs during E-C coupling.
